Bioequivalence studies at night [Regulatives / Guidelines]

posted by Loky do – Egypt, 2022-03-28 14:36 (1197 d 22:14 ago) – Posting: # 22875
Views: 3,340

Dears

Are there any objections (regulatory or in guidelines) or negative effect on the PK of drugs when conducting Bioequivalence studies at night (i.e. volunteers will fast over day and dose will be administrated at night) the dosing hours will be standardized through volunteers and phases? Also the fasting hours before dosing to volunteers as per guidelines are at least 8-10 hours, if it reached 14 hours could it affect the PK of the drug also?

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,696 registered users;
100 visitors (0 registered, 100 guests [including 18 identified bots]).
Forum time: 12:51 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5